Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com

Not every service-related injury is visible. And not every neurological impact shows up right away, which is why early detection can change a veteran's future.
MSP is a rapid, low-cost disease and health disorder symptoms screener that tests for Olfactory Scent losses, which are known symptoms of many hidden disorders.
Veterans face increased risk of traumatic brain injury (TBI) and related neurological challenges due to military training incidents, blast exposure, and impact events. Mild TBI injuries can be especially difficult to recognize—yet they can still affect attention, sleep, mood, memory, and overall quality of life.
VCG Solutions supports efforts that promote early awareness, evidence-based screening education, and stronger pathways to care, so veterans and their families can take action sooner.
Many service-related brain injuries are classified as mild, but the long-term impact can be serious when concerns go unrecognized or unaddressed.
Common challenges include:
Early awareness and screening education can help veterans and care teams identify when follow-up may be needed, ultimately supporting healthier outcomes over time and reducing the long-term burdens for them and their families.
Neurological research has shown that changes in smell sensitivity (olfactory function) can be an early signal of neurological disruption, including concussion and mild TBI.
Why this is important:
This doesn’t replace medical care. It supports awareness and helps guide whether additional clinical evaluation may be appropriate.
As high-level view of rapid neurological screening, these olfactory screening approaches are designed to be simple and non-invasive:
This type of screening is intended to support, not replace, medical diagnosis and care. It works as:
No. Smell-based screening is a screening and awareness tool, not a diagnosis.
Veterans with a history of blast exposure, head impacts, training incidents, or unexplained cognitive/sensory changes may benefit from learning about early screening options.
No. Screening tools are designed to complement clinical care, not replace medical professionals or VA services.
No. Olfactory screening approaches are generally non-invasive and do not involve imaging, needles, or medication.
Because olfactory pathways are closely connected to the brain and can reflect neurological change early.
VCG Solutions does not diagnose or treat. Our role is to support veterans by:
Early screening awareness can support:
If you are a veteran, provider, or organization interested in learning more about neurological health resources, screening education, or partnership opportunities, VCG can help guide the conversation.
Transforming the Future - VCG Solutions.
Copyright © 2023 VCG Solutions, LLC. - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.